四方新材(605122.SH):不存在應披露而未披露的重大事項
格隆匯7月10日丨四方新材(605122.SH)公佈,據Choice智能金融終端2025年7月10日數據顯示,2025年7月7日、7月8日、7月9日、7月10日,公司股票連續四個交易日的累計升幅已達46.52%,公司股票短期內升幅較大,且顯著高於同期上證指數,敬請廣大投資者注意二級市場交易風險。
公司是以商品混凝土研發、生產和銷售為主業,同時生產建築用砂石骨料的建築材料製造商,產品主要銷售市場為重慶市。經公司自查,公司主營業務、日常生產經營活動和外部經營環境均未發生重大變化,公司不存在應披露而未披露的重大事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.